This week, U.S. Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, canceled $500 million in government-funded ...

Secretary Robert F. Kennedy Jr.’s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding will ...

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

Clinical research centers across the US, including the Jacksonville Center for Clinical Research, are being impacted by the Department of Health and Human Services’ announcement to cancel contracts ...

The mRNA vaccines revolutionized pandemic response and are now being explored for cancer and genetic disease treatments, ...

The mRNA molecule eventually breaks down in the body. The Cleveland Clinic reports that the risks of mRNA vaccines include ...

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...

The Trump administration’s move to cut off funding for new vaccine projects that use the groundbreaking mRNA technology ...

Emory’s mRNA project was among 22 cut by DHS Secretary Robert F. Kennedy Jr. despite praise for the technology’s role in fighting COVID and its potential for cancer treatment.

Research that helped develop mRNA vaccines won the Nobel Prize in Physiology or Medicine in 2023. Members of the scientific community are criticizing Kennedy for his decision.